This graphing tool allows users to explore trends in workplace-sponsored health insurance premiums and worker contributions over time for different categories of employers based on results from the annual Employer Health Benefits Survey. Breakouts are available by firm size, region and industry, as well as for firms with relatively few or many part-time workers, higher-…
Today, the Centers for Medicare and Medicaid Services (CMS) released the results from the Medicare Drug Price Negotiation Program for Initial Price Applicability Year (IPAY) 2027 (press release). What was the average reduction in drug prices? Across the 15 drugs included in the 2027 negotiation, on average, drug prices fell by 62% (median: 63%); accounting…
Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California Hospital Association sued Anthem over one of its out-of-network policies, Broward Health sued Florida Blue over alleged underpayment, and Jefferson Health sued Aetna over a Medicare Advantage hospital stay rule. The post Provider-Payer Tensions Brew in Courtrooms:…
Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year. The post Hospital M&A…
Each year, the Indian Health Service rejects tens of thousands of requests to fund outside care that it doesn’t provide, forcing patients to go without treatment or pay big medical bills themselves. The IHS is supposed to provide free care to Native Americans, but it does so only at scattered clinics and hospitals the agency funds and then manages…
We are on the cusp of being held accountable not just for what we did wrong, but for what we failed to do, especially when readily available, life-saving technology could have made a difference. The post When Inaction Becomes Negligence in the Age of AI appeared first on MedCity News.
Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder. The post Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder appeared first on MedCity News.
Presidential candidate Trump claims credit for SCOTUS’ Dobbs decision and says that as a result, the “states are voting.” States are making decisions on abortion policy, but it’s mostly been state legislatures, not voters. Few states with abortion bans have a process for citizen-initiated constitutional amendments. In those states, lawmakers and anti-abortion activists have attempted…
SACRAMENTO, Calif. — The Trump administration is taking its immigration crackdown to the health care safety net, launching Medicaid spending probes in at least six Democratic-led states that provide comprehensive health coverage to poor and disabled immigrants living in the U.S. without permanent legal status. The Centers for Medicare & Medicaid Services is scouring payments…
From cardiovascular disease to Alzheimer’s, the retina is proving to be the body’s most revealing health monitor, positioning optometrists at the forefront of early detection and integrated care. The post Eyes on the Future: How Retinal Imaging Is Reframing Preventive Medicine appeared first on MedCity News.